Green Pine Leads Series Pre-B Plus Round In Chinese Genome Editing Firm EdiGene
February 8, 2019 — 15:11 CST
This Data Is Locked!
This area is available only to Subscribers.
Chinese genome editing technologies developer EdiGene Inc. has secured about US$10 million in its series pre-B plus round of financing led by Chinese venture capital... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals